[Pharmacokinetic study of peplomycin given by continuous infusion from the vagina or cervix in squamous cell carcinoma of the uterine cervix].
D000282:Administration, Intravaginal; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage / Q000493:pharmacokinetics*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000378:metabolism; D002584:Cervix Uteri / Q000378:metabolism; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D017663:Peplomycin; D014018:Tissue Distribution; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000378:metabolism
D001761:Bleomycin; D017663:Peplomycin; D002945:Cisplatin